Slide 1: Preliminary Results for FY 2016
Preliminary Results for FY 2016 February 24, 2017 Stephan Holzinger, CEO Dr. Kai G. Klinger
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights FY 2016
Highlights FY 2016 Campus Bad Neustadt First-time consolidation and integration of Kreisklinik accomplished Opening of fully refurbished 240-bed psychosomatic clinic in May Excellent progress at all construction levels; start of operations in 2019 AGM in June with broad support for all age
Slide 4: Preliminary Results FY 2016: Earnings Influenced by Significant One-off Effects
Preliminary Results FY 2016 * Earnings Influenced by Significant One-off Effects Cases Revenues Organic volume growth +1.2% +6.2% 1,176 (DRG case-mix-points) +3.0 % from 32.8 Kreisklinik +3.0% more organic inpatient and +3.2% organic 1,144 outpatient cases 1,108 growth Total number of treated
Slide 5: Management Board Realignment: New CEO and Slim Down to Three Members
Management Board Realignment New CEO and Slim Down to Three Members Stephan Holzinger as new group CEO from February 1, 2017 Member of the supervisory board of RHÖN-KLINIKUM since 2013 (and later also at UKGM) Corporate experience (BMW, Raytheon) plus some 20 years of broad skills as entrepren
Slide 6: First Thoughts on Strategic Emphases
First Thoughts on Strategic Emphases eHealth and Campus Concept as Key Future Initiatives Pioneer and innovator of patient care H E A LT H C A R E digitalization and cognitive computing in Germany D I G I TA L - I Z AT I O N Leadership in practice of new IN healthcare technologies DEMO- M E G AT R E
Slide 7: Outlook 2017
Outlook 2017 Full financial outlook will be provided later in H1 2017 Parts of corporate strategy as well as 2017 business plan are under high scrutiny It must be assumed that group EBITDA for 2017 will be impacted by structural burdens as well as negative one-time items and should be considerab
Slide 8: Appendix: Financial Calendar
Appendix Financial Calendar FY 2017 February 24, 2017 Preliminary results for financial year 2016 April 7, 2017 Press conference: publication of annual financial report 2016 May 5, 2017 Publication of interim report for the quarter ending March 31, 2017 June 7, 2017 Annual General Meeting (J
Slide 9: Appendix: Price Regulation in 2017 at a Glance
Appendix Price Regulation in 2017 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for 1 RHÖN effective base rate Benchmark (wage sum) DRG inflation in 2017: +2.5%
Slide 10: Appendix: Shareholder Base
Appendix Shareholder Base Shareholder Structure as of December 31, 2016, according to the most recent notifications of voting rights at that time 21.6% 3) B. Braun 42.2% 1) 45.4% Free Float 54.6% Strategic Investors 17.6% Asklepios 10.0% 2) 3.2% 5.4% Eugen Münch/HCM SE Landeskrankenhilfe Ingeborg Mü